Skip to main content

B-Bridge, Pointilliste Align to Market Antibody Array Technology

NEW YORK, March 17 (GenomeWeb News) - B-Bridge International of Sunnyvale, Calif., and Pointilliste of Mountain View, Calif., have expanded their partnership to commercialize Pointilliste's new custom antibody array technology platform, the firms said this week.

The Universal Canvas brand technology mutiplexes nine ELISA assays on a 96-well plate and uses standard imaging systems. The companies, which are also collaborating to market another Pontilliste array product, said the new technology will be available within weeks.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.